What is the prostate?

The prostate is a small gland that forms part of the male reproductive system. It sits just below the bladder and surrounds the urethra, which is the tube that carries urine from the bladder out through the penis.
In younger adult men, the prostate is often described as being about the size of a walnut. However, the prostate commonly becomes larger with age.
Although the prostate is small, its position means it can have a noticeable effect on urinary, sexual and reproductive function. Because the urethra passes directly through the prostate, changes in the size or health of the prostate can sometimes affect the flow of urine.
This is one reason why men with prostate enlargement, inflammation or prostate cancer may experience urinary symptoms. However, it is important to understand that many men with early prostate cancer have no symptoms at all.

The prostate sits below the bladder and surrounds the urethra, which is why prostate conditions can sometimes affect urination.

Where is the prostate?

The prostate is located deep inside the pelvis. It sits:

• below the bladder
• in front of the rectum
• around the upper part of the urethra
• close to the seminal vesicles, which help produce semen

This position explains why doctors may examine the prostate through the rectum during a digital rectal examination, also known as a DRE. It also explains why prostate problems can sometimes affect urination, ejaculation or pelvic comfort.

The prostate is also close to important nerves and muscles involved in erectile function and urinary control. This becomes important when discussing prostate cancer treatment, because treatments such as surgery or radiotherapy may affect nearby structures.

What Does the Prostate Do?

The main role of the prostate is to help produce semen. Semen is the fluid that carries sperm during ejaculation.

The prostate produces fluid that mixes with sperm from the testicles and fluid from the seminal vesicles. This fluid helps support and protect sperm.

The prostate also contains muscle tissue that helps push semen into the urethra during ejaculation. This is why some prostate conditions, and some prostate cancer treatments, can affect ejaculation or sexual function.

Why Can the Prostate Affect Urination?

The prostate surrounds the urethra. If the prostate becomes enlarged, inflamed or affected by disease, it can press on or narrow the urethra. This can make it harder for urine to pass normally.

Men may notice symptoms such as:

• needing to urinate more often
• waking at night to urinate
• a weak urine stream
• difficulty starting urination
• stopping and starting while passing urine
• dribbling after urination
• feeling that the bladder has not emptied properly
• needing to rush to the toilet

These symptoms are common as men get older and are often caused by benign prostate enlargement rather than cancer. However, they should still be assessed properly, especially if they are new, worsening, or affecting quality of life.

Why Urinary Symptoms Do Not Always Mean Prostate Cancer

Many men understandably worry that urinary symptoms may be a sign of prostate cancer. In reality, symptoms such as a weak urine stream, waking at night to pass urine, urgency, or difficulty starting urination are often caused by benign prostate enlargement rather than cancer.

Early prostate cancer often causes no symptoms. This is partly because many prostate cancers begin in the outer part of the prostate, away from the urethra. Urinary symptoms may only appear if the cancer becomes large enough to press on the urethra or has spread.

This means there are two important points to understand:

This is why doctors look at the whole picture. Symptoms matter, but so do age, family history, ethnicity, PSA level, examination findings, MRI results and overall health.

Does the Prostate Change With Age?

Yes. The prostate often grows larger as men get older. This is common and does not automatically mean cancer.

A non-cancerous enlarged prostate is usually called benign prostate enlargement or benign prostatic hyperplasia, often shortened to BPH.

Prostate enlargement can sometimes press on the urethra and affect urinary flow. This may lead to symptoms such as getting up at night to pass urine, a weak stream, urgency, or feeling that the bladder has not emptied properly.

However, prostate size alone does not tell the whole story. Some men with a large prostate have few symptoms. Some men with a smaller prostate may have troublesome urinary symptoms. The effect depends on the position of the enlargement, the bladder, the urethra and other individual factors.

Age is also one of the main risk factors for prostate cancer. For this reason, it is sensible to seek medical advice if you develop new prostate-related symptoms or have concerns about your risk, particularly if you are over 50, have a family history of prostate cancer, or are in a higher-risk group.

The prostate often becomes larger with age. Enlargement is common and does not automatically mean cancer.

Key Patient Context: Prostate Enlargement and Age

What Conditions Can Affect the Prostate?

Several different conditions can affect the prostate. They can sometimes cause similar symptoms, which is why proper assessment matters.

A raised PSA does not automatically mean prostate cancer. PSA can rise because of prostate enlargement, inflammation, infection, recent ejaculation, vigorous cycling, some medical procedures and other causes.

However, a raised PSA may need further investigation, depending on the level, age, symptoms, examination findings and overall risk profile.

Why Understanding the Prostate Matters

Understanding where the prostate is and what it does can make prostate cancer testing and treatment easier to understand.

PSA testing, MRI scans, biopsies and treatment options all relate back to the prostate's position near the bladder, urethra, rectum, reproductive structures and surrounding nerves.

For example:

• urinary symptoms may happen because the prostate surrounds the urethra
• PSA is produced by prostate tissue, which is why it can be measured in a blood test
• MRI scans are used to look for suspicious areas inside the prostate
• biopsies take small samples of prostate tissue
• surgery for prostate cancer usually involves removing the prostate gland
• radiotherapy treats the prostate and sometimes surrounding areas, depending on the cancer stage
• treatments may affect urination, erections or ejaculation because of the prostate's position near the bladder, urethra, nerves and reproductive structures

This does not mean that every man will experience side effects after treatment. It does mean that treatment decisions should be made carefully, with a clear understanding of the potential benefits and risks.

When Should You Seek Medical Advice?

You should speak to a GP or prostate specialist if you notice:

• new or persistent urinary symptoms
• blood in the urine
• blood in the semen
• pain when passing urine
• unexplained pelvic discomfort
• problems getting or keeping an erection
• unexplained bone pain, weight loss or tiredness
• concerns about your prostate cancer risk

You should also consider seeking advice if you have no symptoms but are worried because of your age, family history, ethnicity, previous PSA result or general health concerns.

Many prostate cancers do not cause obvious symptoms in the early stages, so relying on symptoms alone is not always enough.

Common Misconceptions About the Prostate

Key Takeaways

The prostate is a small but important gland that helps produce semen and sits in a position that can affect both urinary and sexual function. Enlargement, inflammation and prostate cancer can sometimes cause similar symptoms, which is why proper assessment matters rather than assumptions based on symptoms alone. A raised PSA does not automatically mean cancer, but it deserves careful interpretation. And because early prostate cancer may cause no symptoms at all, men with risk factors or concerns should not wait for something to feel wrong before seeking advice.

What Is Prostate Cancer?

Prostate cancer is cancer that starts in the prostate gland. The prostate is a small gland below the bladder that helps produce semen and surrounds the urethra, the tube that carries urine out of the body.

Like all cancers, prostate cancer begins when cells start to grow and divide in an abnormal and uncontrolled way. Over time, these cells can form a tumour inside the prostate. Some prostate cancers grow very slowly and may never cause serious harm. Others can grow more quickly and may need active treatment.

This difference is important. A diagnosis of prostate cancer does not automatically mean that urgent treatment is needed, but it does mean the cancer should be assessed carefully. The aim is to understand how aggressive it appears to be, whether it is still within the prostate, and which treatment options are most appropriate for the individual patient.

For many men, prostate cancer is first suspected after a raised PSA blood test, an abnormal prostate examination, an MRI scan or a biopsy. Some men have urinary symptoms, but many men with early prostate cancer have no symptoms at all.

Key Patient Context

What Happens in Prostate Cancer?

The body is made up of cells. Normally, cells grow, divide and die in a controlled way. Cancer can develop when this process goes wrong and cells continue to grow when they should not.

In prostate cancer, abnormal cells develop inside the prostate gland. These cells may form a small tumour. In some men, the cancer grows slowly and remains within the prostate for many years. In others, the cancer may grow more quickly, invade nearby tissues, or spread to other parts of the body.

When prostate cancer spreads, it most commonly spreads to nearby lymph nodes or bones. This is called advanced or metastatic prostate cancer. However, many prostate cancers are found before they have spread, especially when investigated after PSA testing or MRI scanning.

Where Does Prostate Cancer Usually Start?

Many prostate cancers begin in the outer part of the prostate, known as the peripheral zone. This matters because the urethra passes through the central part of the prostate. A cancer growing in the outer part may not press on the urethra early on.

This is one reason early prostate cancer often does not cause urinary symptoms. Urinary problems such as a weak stream, waking at night to pass urine, urgency or difficulty starting urination are common in older men, but they are often caused by benign prostate enlargement rather than prostate cancer.

That does not mean urinary symptoms should be ignored. New, persistent or worsening urinary symptoms should be assessed. However, it also means that relying on symptoms alone is not a reliable way to rule out prostate cancer.

Prostate Cancer Is Not One Single Situation

One of the most important things to understand is that prostate cancer varies widely from one man to another.

Some prostate cancers are low-risk and slow-growing. These may be monitored carefully with active surveillance rather than treated immediately. Other prostate cancers are more aggressive and are more likely to need treatment such as surgery, radiotherapy, hormone therapy, or a combination of treatments.

The right approach depends on several factors, including PSA level, MRI findings, biopsy results, Gleason score or Grade Group, cancer stage, general health, age, life expectancy and personal priorities.

Localised, Locally Advanced and Metastatic Prostate Cancer

Doctors often describe prostate cancer according to how far it has spread. This helps guide treatment decisions.

This classification is not based on one test alone. It usually depends on a combination of PSA blood test results, MRI scan findings, biopsy results and, in some cases, additional imaging scans.

A man with localised prostate cancer may have several treatment options. A man with metastatic prostate cancer usually needs a different treatment plan. This is why accurate diagnosis and staging are so important.

What Type of Cancer Is Prostate Cancer?

Most prostate cancers are adenocarcinomas. This means they start in the gland cells of the prostate, which are the cells involved in producing prostate fluid.

There are rarer types of prostate cancer, including small cell prostate cancer, neuroendocrine prostate cancer, transitional cell cancer and sarcoma. These are much less common and may behave differently from typical prostate adenocarcinoma.

For most patients, the key issue is not simply the type of prostate cancer, but its risk category. This is assessed using PSA, MRI, biopsy, Grade Group, stage and other clinical details.

How Is Prostate Cancer Usually Found?

Prostate cancer may be suspected in several ways. Some men have a raised PSA blood test. Some have an abnormal prostate examination. Some have urinary symptoms that lead to further tests. Others are investigated because they have a family history or are in a higher-risk group.

A diagnosis of prostate cancer is usually confirmed by a biopsy, where small samples of prostate tissue are taken and examined under a microscope. Before biopsy, many men now have an MRI scan to look for suspicious areas in the prostate and help guide the next steps.

What Doctors Need to Understand After Prostate Cancer Is Suspected

The aim of investigation is not only to find out whether prostate cancer is present. It is also to understand the behaviour of the cancer and the safest, most appropriate treatment plan.

The main questions are:

• Is prostate cancer present?
• If cancer is present, how aggressive does it appear to be?
• Is the cancer contained within the prostate?
• Has it grown just outside the prostate?
• Has it spread to lymph nodes, bones or other areas?
• What are the likely benefits and risks of each treatment option?
• What matters most to the patient, including cancer control, urinary function, erectile function, recovery time and quality of life?

Common Misconceptions About Prostate Cancer

Why Clear Information Matters

Prostate cancer decisions can be difficult because treatment is not only about removing or controlling cancer. It is also about balancing cancer control with side effects, recovery and long-term quality of life.

For example, surgery and radiotherapy can both be appropriate treatments for suitable patients, but they have different risks and recovery patterns. Active surveillance may be appropriate for some men with low-risk disease, but may not be suitable for more aggressive cancer.

This is why a proper discussion with a prostate cancer specialist is important. Patients should understand their diagnosis, their risk category, the realistic treatment options and the potential impact of each option before making a decision.

Key Points

Key Takeaways

• Prostate cancer is not one single disease; it can range from slow-growing to aggressive.
• A man can have early prostate cancer without any urinary symptoms.
• The main purpose of testing is to understand whether cancer is present, how aggressive it is and whether it has spread.
• Some men may be suitable for active surveillance, while others may need active treatment.
• Good treatment decisions depend on clear information, accurate staging and an honest discussion about benefits, risks and quality of life.

Next in This Guide

• How Common Is Prostate Cancer?
• What Causes Prostate Cancer and Can It Be Prevented?
• Risk Factors for Prostate Cancer
• Symptoms of Prostate Cancer
• How Do I Get Tested for Prostate Cancer?

How Common Is Prostate Cancer?

Prostate cancer is one of the most common cancers affecting men in the UK. It is also one of the cancers most likely to raise difficult questions, because being common does not mean that every case behaves in the same way.

Some prostate cancers are slow-growing and may never cause serious harm. Others are more aggressive and need prompt treatment. For patients, the most useful question is not only, 'How common is prostate cancer?' It is also, 'What does my personal risk look like, and what should I do about it?'

According to Prostate Cancer UK, prostate cancer is now the most commonly diagnosed cancer in the UK. The charity reports that more than 64,000 men are diagnosed with prostate cancer each year, more than 12,000 men die from the disease each year, and around 540,000 men are living with or after prostate cancer.

These numbers are important, but they need to be understood carefully. Prostate cancer is common, particularly as men get older, but many men diagnosed with prostate cancer live for many years. Outcomes depend on several factors, including the stage of the cancer, how aggressive it appears under the microscope, PSA level, MRI findings, general health, treatment suitability and whether the cancer is found before it has spread.

Key UK Statistics

The figures below give useful context for UK patients. Different organisations sometimes report slightly different numbers because they may use different years, countries within the UK, registration methods or statistical models. The overall message is consistent: prostate cancer is common, age-related, and a major cause of cancer diagnosis in men.

Why Is Prostate Cancer So Common?

One of the main reasons prostate cancer is common is age. The prostate changes as men get older, and the risk of prostate cancer rises significantly with age. Most prostate cancers are diagnosed in men over 50, and Cancer Research UK reports that incidence rates are highest in men aged 75 to 79.

This does not mean younger men cannot develop prostate cancer. It means that the probability increases as men move through midlife and older age. This is why discussions around risk often begin from the age of 50, or earlier for men in higher-risk groups.

Another reason more cases are being recorded is that more men are being tested, investigated and diagnosed. PSA blood testing, MRI scanning and greater public awareness can all increase the number of cancers detected. Recent public awareness campaigns and high-profile diagnoses have also encouraged more men to ask about prostate cancer risk.

An increase in recorded diagnoses does not automatically mean that prostate cancer is biologically becoming more aggressive. It may partly reflect a growing and ageing population, increased testing, improved diagnostic pathways and more men coming forward. However, it still matters because every diagnosis needs to be assessed properly so that significant cancers are not missed and low-risk cancers are not overtreated.

Clinical Context: Common Does Not Always Mean Dangerous

The word 'common' can sound frightening, but it should not be interpreted as meaning that every prostate cancer is immediately dangerous. Prostate cancer covers a wide spectrum of disease.

At one end are low-risk cancers that may grow so slowly that immediate treatment is not needed. These may be monitored through active surveillance, which usually involves PSA testing, repeat MRI scans, clinical review and sometimes further biopsies. At the other end are high-risk or advanced cancers that can grow more quickly and may need treatment such as surgery, radiotherapy, hormone therapy, chemotherapy, newer systemic therapies, or a combination of treatments.

This is why diagnosis is only the first step. Once prostate cancer is found, doctors need to understand the risk category. That usually means looking at the PSA level, MRI scan, biopsy findings, Gleason score or Grade Group, cancer stage and the patient's general health. Two men can both be diagnosed with prostate cancer but need very different management plans.

Who Is More Likely to Develop Prostate Cancer?

Every man has some risk of prostate cancer, but the level of risk is not the same for everyone. Some factors are strongly linked with a higher chance of developing the disease.

Is Prostate Cancer Becoming More Common?

Recent UK data suggests that recorded prostate cancer diagnoses have increased. NHS England cancer registration statistics show that prostate cancer was the most diagnosed cancer in England in 2023, with 58,137 new diagnoses, a 6% increase from 2022. Prostate Cancer UK has also reported a sharp rise in UK diagnoses over the last decade.

There are several possible reasons for this. The population is ageing, and prostate cancer is more common in older men. More men are also aware of prostate cancer and are asking for PSA testing or specialist assessment. Diagnostic pathways have changed, with MRI now playing a much larger role before biopsy. These factors can increase the number of cancers found.

The Lancet Commission on prostate cancer, published in 2024, projected that global prostate cancer cases could rise from 1.4 million in 2020 to 2.9 million by 2040. This projection is driven largely by ageing populations worldwide and has important implications for healthcare planning. For individual patients in the UK, it reinforces a clear message: prostate cancer will become an even more significant health issue in the coming decades, making awareness, risk assessment and early diagnosis increasingly important.

For individual patients, this does not mean panic. It means awareness. Men should understand their personal risk, know when to ask about PSA testing, and seek advice if they develop concerning symptoms or have risk factors such as Black ethnicity, a strong family history or inherited cancer gene changes.

Why Early Diagnosis Matters

Prostate cancer is often more treatable when it is found before it has spread outside the prostate. Localised prostate cancer may be managed in several ways, including active surveillance, robotic prostate surgery, radiotherapy, brachytherapy or focal therapy in selected cases. Once prostate cancer has spread to distant parts of the body, treatment usually focuses on controlling the disease rather than curing it.

This is why prevalence statistics matter. A common cancer that often causes no early symptoms creates a difficult situation: many men feel perfectly well at the stage when testing may be most useful. Urinary symptoms, when present, are often caused by benign prostate enlargement rather than cancer. That means symptoms alone are not a reliable screening tool.

At the same time, testing has to be used sensibly. PSA testing can help identify men who need further investigation, but PSA is not a cancer-specific test. It can be raised by benign prostate enlargement, inflammation, infection, recent ejaculation, cycling and some medical procedures. A raised PSA is therefore not a diagnosis; it is a reason to interpret the result carefully and consider whether further assessment is needed.

Modern prostate cancer diagnosis increasingly relies on combining information rather than making decisions from one result alone. PSA level, PSA density, clinical examination, MRI findings, biopsy results and personal risk factors all help build a clearer picture.

Why There Is No Simple One-Size-Fits-All Screening Message

One of the most common questions is: if prostate cancer is so common, why is every man not automatically screened? The answer is that prostate cancer testing involves a balance of benefits and harms.

Testing can help detect prostate cancer earlier, including cancers that may become dangerous if not treated. However, it can also detect slow-growing cancers that may never have caused symptoms or shortened life. This is called overdiagnosis. Overdiagnosis can lead to anxiety, repeated tests and, in some cases, treatment that may not have been needed.

This is why UK practice places emphasis on informed decision-making. Men should be able to discuss the possible benefits and limitations of PSA testing, especially if they are over 50 or in a higher-risk group. For some men, testing may be sensible. For others, the decision may be less straightforward.

The key point is not that men should ignore prostate cancer risk. The key point is that testing should be thoughtful, informed and interpreted by clinicians who understand prostate cancer diagnosis.

Common Misconceptions About How Common Prostate Cancer Is

What This Means for Patients

The practical message is simple: prostate cancer is common enough that men should know their risk, but varied enough that decisions should be individualised.

Men over 50 should consider discussing prostate cancer risk with their GP or a prostate specialist, particularly if they are concerned about PSA testing or have urinary symptoms. Black men, men with a family history of prostate cancer, and men with known inherited cancer gene changes may need to start that conversation earlier.

Men should also understand that being diagnosed with prostate cancer does not automatically mean rushing into treatment. The first priority is to understand the cancer properly. Is it low-risk or higher-risk? Is it confined to the prostate? What does the MRI show? What does the biopsy show? What are the realistic treatment options? What are the likely effects on urinary control, erections and quality of life?

Good care is not just about fighting prostate cancer. It is about identifying clinically significant prostate cancer, avoiding unnecessary harm where possible, and choosing the right approach for the right patient.

Key Takeaways

Prostate cancer is one of the most common cancers in the UK, with more than 64,000 diagnoses and 12,000 deaths recorded each year — yet most men diagnosed with it will live for many years, and survival rates have improved substantially over recent decades. Risk rises with age, but it is not evenly distributed: Black men, men with a family history of prostate cancer, and those with inherited gene changes such as BRCA2 face a meaningfully higher risk and should consider discussing testing earlier. Because early prostate cancer often causes no symptoms at all, a raised PSA or specialist referral should be seen not as cause for alarm, but as an opportunity to understand the picture properly. Some cancers will need treatment; others can be safely monitored. The most important step is an accurate, individualised assessment — and the right clinician to help interpret it.

What Causes Prostate Cancer and Can It Be Prevented?

There is rarely one single cause of prostate cancer. Like most cancers, it develops when changes occur inside cells, allowing them to grow and divide in an abnormal way. Over time, these abnormal cells can form a tumour in the prostate gland.

For most men, it is not possible to point to one clear reason why prostate cancer has developed. It is usually the result of a combination of factors, including age, inherited risk, ethnicity, hormones, biological processes and possibly lifestyle. Some of these factors cannot be changed. Others may be influenced by general health, body weight and activity levels.

This distinction matters. A man should not assume that prostate cancer is his fault, or that he could definitely have prevented it by eating differently or living differently. At the same time, understanding risk factors can help men make sensible decisions about when to speak to a doctor, when to consider PSA testing, and how to look after their wider health.

The most helpful way to think about this topic is not simply, 'What caused it?' but rather: 'Am I at higher risk, and what can I do about that risk?'

Key Facts About Causes and Prevention

What Actually Causes Prostate Cancer?

Cancer begins when the instructions inside cells become damaged or altered. These instructions are carried in DNA. Normally, the body has systems to repair DNA damage or remove cells that are not behaving normally. Cancer can develop when these systems fail and abnormal cells keep growing.

In prostate cancer, this happens within cells of the prostate gland. Most prostate cancers are adenocarcinomas, meaning they start in glandular cells that help produce prostate fluid. The behaviour of these cancer cells can vary widely. Some grow slowly over many years, while others are more aggressive and more likely to spread.

Male hormones, especially androgens such as testosterone, are also involved in the biology of the prostate. Prostate cells rely on androgen signalling to grow and function. This does not mean that normal testosterone levels cause prostate cancer, but it helps explain why hormone therapy can be used to treat some prostate cancers by reducing or blocking androgen activity.

In practical terms, most men will never know the exact biological trigger that started their prostate cancer. What doctors can assess more reliably is the man's risk profile: PSA level, MRI findings, biopsy result, Grade Group and stage. These details are far more useful for making decisions than trying to identify one single cause.

Risk Factors You Cannot Change

Some of the strongest prostate cancer risk factors are not lifestyle choices. They are related to age, ancestry, family history and inherited genes.

Age and Prostate Cancer Risk

Age is one of the most important prostate cancer risk factors. Prostate cancer can occur in younger men, but it is much less common before the age of 50 unless there are additional risk factors such as a family history or an inherited gene change.

The reason age matters is that cell changes can accumulate over time. As men get older, the prostate has had more years of exposure to hormonal, genetic and biological changes. This does not mean every older man will develop prostate cancer, but it does mean risk rises with age.

This is why conversations about PSA testing often begin around age 50 for men at average risk, and earlier for some men at higher risk. A man's age should always be considered alongside his family history, ethnicity, symptoms and personal concerns.

Family History and Genetic Risk

Family history is important because some prostate cancers are influenced by inherited genes. According to Cancer Research UK, inherited factors are estimated to explain around 5 to 9% of prostate cancers. That does not mean family history is directly inherited, but it does mean family history should be taken seriously.

Risk may be higher if a close male relative, such as a father or brother, has had prostate cancer. Risk may be higher still if more than one close relative has been affected, or if relatives were diagnosed at a younger age. A family history of breast, ovarian or pancreatic cancers may also be relevant because some of these cancers can be linked through inherited gene changes such as BRCA2.

A BRCA2 gene change does not mean a man will definitely develop prostate cancer. However, it can increase risk and may be associated with more aggressive disease. In May 2026, following a full evidence review, the UK National Screening Committee published its recommendation for targeted prostate cancer screening for a specific high-risk group — a recommendation formally accepted by the UK Government on 2 June 2026.

Men who are worried about a strong family history should discuss this with a GP, urologist or genetics specialist. Genetic testing is not needed for everyone, but it may be considered when the family pattern suggests an inherited cancer risk.

Ethnicity and Prostate Cancer Risk

Ethnicity is another important risk factor. Black men are more likely to develop prostate cancer than men from other ethnic groups, and may also be diagnosed at a younger age. Prostate Cancer UK states that about 1 in 4 Black men in the UK will get prostate cancer during their lifetime, compared with about 1 in 8 men overall.

The reasons for this increased risk are not fully understood. Genetics may play a role, but access to healthcare and evidence review of ethnic differences in how early cancer is detected may also matter. It is important not to reduce this risk to one simple explanation.

For patients, the practical message is clear: Black men should be aware of their higher risk and should consider speaking to a GP or prostate specialist from the age of 45, or earlier if they have symptoms or a strong family history.

The 2026 UK NSC review acknowledged that, for Black men, there is ongoing uncertainty about whether the benefits of screening would outweigh the harms. The TRANSFORM trial — a major UK research programme — is actively working to generate the evidence needed to resolve this uncertainty, and the UK NSC has confirmed it will use findings from TRANSFORM to inform future screening decisions. This is an area where guidance is expected to evolve.

Can Lifestyle Affect Prostate Cancer Risk?

Lifestyle is more complicated. There is no single diet, supplement or exercise routine that can guarantee protection from prostate cancer. However, lifestyle may influence the risk of more aggressive or advanced disease, and it also affects general health, treatment fitness and recovery.

The World Cancer Research Fund's evidence review on diet, nutrition, physical activity and prostate cancer found that being overweight or obese is linked to an increase in the risk of advanced prostate cancer. Prostate Cancer UK also advises that a healthy diet and regular exercise are important for maintaining a healthy weight, which may help lower the risk of aggressive or advanced prostate cancer.

This does not mean that every man who is overweight will develop prostate cancer, or that a man of healthy weight cannot develop prostate cancer. It means body weight is one of the few potentially modifiable factors that may influence the risk of more serious prostate cancer.

Can Prostate Cancer Be Prevented?

There is no guaranteed way to prevent prostate cancer. This is because some of the most important risk factors, such as age, ethnicity and inherited genes, cannot be changed.

That can be frustrating, but it is also important. Men should not blame themselves if they develop cancer. Prostate cancer is common, and many men who develop it have lived healthy lives.

Prevention should therefore be understood in a realistic way. The aim is not to promise that prostate cancer can be avoided completely. The aim is to reduce avoidable risks where possible, support general health, and identify higher-risk men early enough for sensible testing and discussion.

For many men, the most practical steps are to keep a healthy weight, stay active, eat a balanced diet, understand their family history, and seek advice if they are in a higher-risk group. These steps may not prevent every case, but they can improve overall health and may reduce the risk of advanced or aggressive disease.

Prevention Is Not the Same as Early Detection

One common misunderstanding is to confuse prevention with early detection. Prevention means reducing the chance of developing a disease in the first place. Early detection means finding a disease at an earlier stage, when treatment may be more effective.

PSA testing, MRI scanning and biopsy do not prevent prostate cancer. They help assess whether cancer may already be present and how concerning it appears to be. This distinction matters because a man can do everything right and still develop prostate cancer, and a man can have no symptoms but still have early disease.

In the UK, there is not a universal prostate cancer screening programme for all men. The 2026 UK NSC review concluded that population-wide screening is more likely to cause harm than good, primarily because of the risks of overdiagnosis and unnecessary treatment — including incontinence and erectile dysfunction in men who may not have needed intervention. However, men can still speak to a GP about PSA testing, especially if they are over 50 or at higher risk. The decision should be informed and individual.

Does Diet Cause Prostate Cancer?

There is no good evidence that one ordinary food directly causes prostate cancer in a simple way. Claims that a single food either causes or prevents prostate cancer are usually too simplistic.

Research into diet and prostate cancer is difficult because people eat complex diets over many years, and many factors influence cancer. For example, diet, body weight, physical activity, alcohol intake, smoking, social factors and access to healthcare can all interact.

The safest patient message is that a balanced diet supports overall health and weight management. It should not be sold as a guaranteed way to prevent prostate cancer. Men should be cautious about extreme diets, miracle foods, high-dose supplements, or online claims that promise cancer prevention.

Common Misconceptions About Causes and Prevention

When Should You Think About Your Risk?

It is sensible to think about prostate cancer risk if you are over 50, or over 45 and Black, or over 45 with a family history of prostate cancer. You should also seek advice if you have urinary symptoms, blood in the urine or semen, unexplained pelvic discomfort, new erectile problems, unexplained weight loss, bone pain, or any concern that something has changed.

Men with a strong family history of prostate, breast, ovarian or pancreatic cancer should also consider discussing risk with a doctor, particularly if relatives were diagnosed at younger ages. In some situations, a genetics referral may be appropriate. Men with a confirmed BRCA2 variant and a relevant family history should ask specifically about the new targeted screening programme and what it means for them.

The right approach depends on the individual. Some men may need reassurance and monitoring. Others will benefit from discussion, PSA testing, MRI screening or specialist assessment. The important point is that risk should be discussed early enough for informed decisions, rather than waiting for symptoms to become severe.

Key Takeaways

Prostate cancer rarely has one identifiable cause — for most men it results from a combination of age, inherited risk, ethnicity and biology rather than anything they have done. The strongest risk factors are ones that cannot be changed: being over 50, being a Black man, having a family history of prostate cancer, or carrying an inherited BRCA2 gene change. In May 2026, following a full evidence review, the UK NSC recommended targeted PSA screening every two years for men aged 45 to 61 with a confirmed BRCA2 variant and a relevant family history — a recommendation formally accepted by the UK Government in June 2026, with rollout in England expected from 2027. For Black men, the evidence on screening remains under active investigation through the TRANSFORM trial, and guidance in this area is expected to evolve. Lifestyle cannot guarantee prevention, but maintaining a healthy weight, staying active and eating well may reduce the risk of more aggressive disease and supports overall health and treatment fitness. The most important step for any man is to understand his personal risk — and to have that conversation early enough to act on it.